• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Transcriptomics Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 Product Image

Transcriptomics Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

  • ID: 2673552
  • October 2013
  • Region: Global
  • 97 Pages
  • Transparency Market Research

FEATURED COMPANIES

  • Affymetrix, Inc
  • Agilent Technologies, Inc
  • Bio-Rad Laboratories, Inc
  • Danaher Corporation
  • F Hoffmann-La Roche Ltd
  • Illumina, Inc
  • MORE

'Transcriptomics Technologies Market (Microarrays, PCR, Gene Regulation and Next Generation Sequencing) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019'

Transcriptomics refers to the structural and functional aspects of a complete set of transcripts present in an individual or group of cells. The demand for transcriptomics research is increasing due to the consistent technological upgrades in several techniques (such as polymerase chain reaction (PCR), ribonucleic acid (RNA) sequencing and microarrays, etc.) employed for transcriptome analysis.

Other notable factors include increased research in the field of “omics” technologies followed by heightened preference for personalized medicine which further propels the transcriptomics market growth. The major technologies employed for transcriptome analysis include microarrays, PCR, gene regulation studies and next generation sequencing technologies. Transcriptomics research provides a lucrative business opportunity to several pharmaceutical and biotechnological companies as these technologies possess wide application areas such as drug discovery and research followed by clinical READ MORE >

FEATURED COMPANIES

  • Affymetrix, Inc
  • Agilent Technologies, Inc
  • Bio-Rad Laboratories, Inc
  • Danaher Corporation
  • F Hoffmann-La Roche Ltd
  • Illumina, Inc
  • MORE

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 List of Abbreviations

Chapter 2 Executive Summary

Chapter 3 Market Overview
3.1 Introduction
3.1.1 Market Potential of Transcriptomics Technologies
3.1.2 Future Scenario of Transcriptomics
3.1.3 Market Dynamics
3.2 Market Drivers
3.2.1 Technological Advancements
3.2.2 Rising Preference for Personalized Medicine from both ends (Manufacturers and Consumers)
3.2.3 Increasing Research and Development Investments
3.2.4 Impact Analysis of Market Drivers
3.3 Market Restraints
3.3.1 Lack Of Efficient Data Analysis Tools
3.3.2 Impact Analysis of Market Restraints
3.4 Market Opportunities
3.4.1 Focus on Development of Bioinformatics Tools and Services
3.5 Porter’s Five Forces Analysis: Global Transcriptomics Technologies Market
3.5.1 Bargaining Power Of Buyers
3.5.2 Bargaining Power Of Suppliers
3.5.3 Threat of Substitutes
3.5.4 Threat of New Entrants
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis: Global Transcritpomics Technologies Market, By Geography

Chapter 4 Global Transcriptomics Technologies Market, By Technology
4.1 Introduction
4.2 Microarrays
4.2.1 Global Microarrays Market, Size and Forecast, 2011 - 2019 (USD Million)
4.2.2 Polymerase Chain Reaction (PCR)
4.2.2.1 Global PCR Market, Size and Forecast, 2011 - 2019 (USD Million)
4.2.3 Gene Regulation Technologies (RNA Interference Technology)
4.2.3.1 Global Gene Regulation Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)
4.2.4 Next Generation Sequencing (NGS)
4.2.4.1 Global Next Generation Sequencing Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

Chapter 5 Global Transcriptomics Technologies Market, By Application
5.1 Overview
5.2 Clinical Diagnostics
5.2.1 Global Clinical Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million)
5.3 Drug Discovery And Research
5.3.1 Global Drug Discovery and Research Market, Size and Forecast, 2011 - 2019 (USD Million)
5.4 Bioinformatics
5.4.1 Global Bioinformatics Market, Size and Forecast, 2011 - 2019 (USD Million)
5.5 Comparative Transcriptome Studies
5.5.1 Global Comparative Transcriptome Studies Market, Size and Forecast, 2011 - 2019 (USD Million)

Chapter 6 Global Transcriptomics Technologies Market, By Geography
6.1 Overview
6.1.1 Global Transcriptomics Technologies Market, By Geography, Size and Forecast, 2011 – 2019 (USD Million)
6.1.2 Comparative Analysis: Global Transcriptomics Technologies Market, By Geography, 2012 & 2019 (Value %)
6.2 North America
6.2.1 North America Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)
6.3 Europe
6.3.1 Europe Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)
6.4 Asia-Pacific
6.4.1 Asia-Pacific Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)
6.5 Rest of the World (Row)
6.5.1 Row Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

Chapter 7 Competitive Landscape
7.1 Market Share By Key Players: Global Transcriptomics Technologies Market, 2012 (%)

Chapter 8 Recommendations
8.1 Collaboration with Academic and Research Institutes
8.2 Focus on Imparting Education about Genomic Medicine

Chapter 9 Company Profiles
9.1 Affymetrix, Inc.
9.1.1 Company Overview
9.1.2 Financial Overview
9.1.3 Product Portfolio
9.1.4 Business Strategies
9.1.5 Recent Developments
9.2 Agilent Technologies, Inc.
9.2.1 Company Overview
9.2.2 Financial Overview
9.2.3 Product Portfolio
9.2.4 Business Strategies
9.2.5 Recent Developments
9.3 Bio-Rad Laboratories, Inc.
9.3.1 Business Overview
9.3.2 Financial Overview
9.3.3 Product Portfolio
9.3.4 Business Strategies
9.3.5 Recent Developments
9.4 Danaher Corporation
9.4.1 Business Overview
9.4.2 Financial Overview
9.4.3 Product Portfolio
9.4.4 Business Strategies
9.4.5 Recent Developments
9.5 F. Hoffmann-La Roche Ltd.
9.5.1 Company Overview
9.5.2 Financial Overview
9.5.3 Product Portfolio
9.5.4 Business Strategies
9.5.5 Recent Developments
9.6 Illumina, Inc.
9.6.1 Company Overview
9.6.2 Financial Overview
9.6.3 Product Portfolio
9.6.4 Business Strategies
9.6.5 Recent Developments
9.7 Life Technologies Corporation
9.7.1 Company Overview
9.7.2 Financial Overview
9.7.3 Product Portfolio
9.7.4 Business Strategies
9.7.5 Recent Developments
9.8 LC Sciences, LLC
9.8.1 Company Overview
9.8.2 Financial Overview
9.8.3 Product Portfolio
9.8.4 Business Strategies
9.8.5 Recent Developments
9.9 Qiagen N.V.
9.9.1 Company Overview
9.9.2 Financial Overview
9.9.3 Product Portfolio
9.9.4 Business Strategies
9.9.5 Recent Developments
9.10 Sigma-Aldrich Corporation
9.10.1 Company Overview
9.10.2 Financial Overview
9.10.3 Product Portfolio
9.10.4 Business Strategies
9.10.5 Recent Developments
9.11 Thermo Fisher Scientific
9.11.1 Company Overview
9.11.2 Financial Overview
9.11.3 Product Portfolio
9.11.4 Business Strategies
9.11.5 Recent Developments

List of Figures

FIG. 1 Central Dogma: Transcriptomics Technologies Market
FIG. 2 Transcriptomics Technologies: Market Segmentation
FIG. 3 Global Transcriptomics Technologies Market, By Technology, 2012 (USD Million)
FIG. 4 Porter’s Five Forces Analysis: Global Transcriptomics Technologies Market
FIG. 5 Market Attractiveness Analysis: Global Transcriptomics Technologies Market, By Geography
FIG. 6 Global Microarrays Market, Size and Forecast, 2011 - 2019 (USD Million)
FIG. 7 Global PCR Market, Size and Forecast, 2011 - 2019 (USD Million)
FIG. 8 Global Gene Regulation Market, Size and Forecast, 2011 - 2019 (USD Million)
FIG. 9 Global Next Generation Sequencing Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)
FIG. 10 Global Clinical Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million)
FIG. 11 Global Drug Discovery Market, Size and Forecast, 2011 - 2019 (USD Million)
FIG. 12 Global Bioinformatics Market, Size and Forecast, 2011 - 2019 (USD Million)
FIG. 13 Global Comparative Transcriptome Studies Market, Size and Forecast, 2011 - 2019 (USD Million)
FIG. 14 Comparative Analysis: Global Transcriptomics Technologies Market, By Geography, 2012 & 2019 (Value %)
FIG. 15 North America Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)
FIG. 16 Europe Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)
FIG. 17 Asia-Pacific Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)
FIG. 18 Row Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)
FIG. 19 Market Share Analysis: Global Transcriptomics Technologies Market, 2012 (%)
FIG. 20 Affymetrix, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 21 Agilent Technologies, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 22 Bio-Rad Laboratories, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 23 Danaher Corporation, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 24 F. Hoffmann-La Roche Ltd., Annual Revenue: 2010 – 2012 (USD Million) (1 CHF = 1.09 USD)
FIG. 25 Illumina, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 26 Life Technologies Corporation, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 27 Qiagen N.V., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 28 Sigma Aldrich Corporation, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 29 Thermo Fisher Scientific, Annual Revenue: 2010 – 2012 (USD Million)

List of Tables

TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global Transcriptomics Technologies Market
TABLE 3 Impact Analysis of Market Drivers
TABLE 4 Impact Analysis of Market Restraints
TABLE 5 Global Transcriptomics Technologies Market, By Technology, Size and Forecast, 2011-2019 (USD Million)
TABLE 6 Global Transcriptomics Technologies Market, By Application, Size and Forecast, 2011-2019 (USD Million)
TABLE 7 Global Transcriptomics Technologies Market, By Geography, Size and Forecast, 2011 – 2019(USD Million)

FEATURED COMPANIES

  • Affymetrix, Inc
  • Agilent Technologies, Inc
  • Bio-Rad Laboratories, Inc
  • Danaher Corporation
  • F Hoffmann-La Roche Ltd
  • Illumina, Inc
  • MORE

Transcriptomics is one of the flourishing “Omics” technologies (proteomics, genomics, metabolomics and others) across the globe. Transcriptomics research provides insights on the structure and function of a complete set of RNA molecules present in a given cell. Currently, the analysis of transcriptome of several organisms is facilitated with the help of advanced technological platforms such as next generation sequencing platforms followed by polymerase chain reaction, microarrays and gene regulation technologies. These technologies are applied in the process of drug discovery, medical research, clinical diagnosis of diseases and others. With the burgeoning demand for targeted therapeutics and continuous improvements in healthcare infrastructure, transcriptomics technologies promise lucrative commercialization prospects. Hence, transcriptomics research enables development of potential and novel therapeutics and diagnostics.

Evolution of technological analysis platforms such as next generation sequencing technologies, microRNA technology, RNA interference technology and PCR technologies enable effective analysis of transcriptome of different organisms with greater precision and accuracy. Currently, there is a demand for technology sophistication to ensure optimum results. For example, presently, there is a need for multiplexed RNA sequencing and quantagene RT-PCR which enable the sequencing and analysis of numerous transcripts and reads simultaneously. These technological sophistications in turn create a demand for effective data analysis tools and service (bioinformatics) in order to handle and manage huge amount of data from these technological platforms.

Transcriptomics technologies are applied in studying gene expression patterns, drug discovery and clinical diagnosis of disorders such as cardiovascular, central nervous system disorders, cancers and others. Transcriptome analysis tools and services are used in identification of novel gene sequences and potential drug targets. Also, they provide insights about gene expression patterns and gene regulation mechanisms that are responsible to trigger the functioning and production of proteins. There is a lot of complexity involved in study of structural and functional aspects of complete set of transcripts present in a given cell or population of cells. Henceforth, several pharmaceutical and biotechnology companies are investing in medical research to develop robust methodologies with high efficiency and reliability.

Geographically, North America dominated the global transcriptomics technologies market in 2012 with a revenue share of over 35%. The presence of well equipped medical and research laboratories, increased awareness of biotechnological research and increased participation of respective governments are some of the major factors responsible for region’s leadership position. Factors such as continuous improvisation in healthcare infrastructure, rigorous research and development initiatives followed by increased commercialization of research outcomes are expected to drive the growth of this market during the forecast period. In Asia-Pacific region ongoing development of technologies and infrastructure facilities along with increasing acceptance towards the novel approaches in biotechnology research will further enhance the uptake of transcriptomics technologies and drive market growth. On the other hand factors which might hamper the growth of overall transcriptomics market are lack of effective computational biology tools and services required for efficient analysis of complex data followed by lack of domain expertise.

- Affymetrix, Inc
- Agilent Technologies, Inc
- Bio-Rad Laboratories, Inc
- Danaher Corporation
- F Hoffmann-La Roche Ltd
- Illumina, Inc
- LC Sciences, LLC
- Life Technologies Corporation
- Qiagen NV
- Sigma-Aldrich Corporation
- Thermo Fisher Scientific

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos